Malignant-hyperthermia susceptibility is associated with a mutation of the α1-subunit of the human dihydropyridine-sensitive L-type voltage- dependent calcium-channel receptor in skeletal muscle

American Journal of Human Genetics

Volumn 60, Issue 6, 1997, Pages 1316-1325

  Monnier, Nicole ^a   Procaccio, Vincent ^a,b   Stieglitz, Paul ^a   Lunardi, Joël ^a,b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b CEA GRENOBLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; DIHYDROPYRIDINE; RYANODINE RECEPTOR;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; DISEASE PREDISPOSITION; DNA DETERMINATION; EXCITATION CONTRACTION COUPLING; GENE LOCUS; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; HUMAN; HYPOKALEMIC PERIODIC PARALYSIS; MALE; MALIGNANT HYPERTHERMIA; PHENOTYPE; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SEQUENCE ANALYSIS; SKELETAL MUSCLE;

EID: 0030922550     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/515454     Document Type: Article

References (52)

1. Bean BP (1984) Nifedipine block of cardiac calcium channels: high affinity binding to the inactivated state. Proc Natl Acad Sci USA 81:6388-6392
2. Catterall WA (1988) Structure and function of voltage-sensitive ion channels. Science 242:50-61
3. Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
4. De Jongh KS, Merrick DK, Catterall WA (1989) Subunits of purified calcium channels: a 212-kDa form of α1-and partial amino acid sequence of a phosphorylation site of an independent β subunit. Proc Natl Acad Sci USA 86:8585-8589
5. De Jongh KS, Warner C, Colvin AA, Catterall WA (1991) Characterization of the two forms of the α1-subunit of skeletal muscle L-type calcium channels. Proc Natl Acad Sci USA 88:10778-10782
6. Deufel T, Golla A, Iles D, Meindl A, Meitinger T, Schindelhauer D, DeVries A, et al (1992) Evidence for genetic heterogeneity of malignant hyperthermia susceptibility. Am J Hum Genet 50:1151-1161
7. De Waard M, Liu H, Walker D, Scott VES, Gurnett CA, Campbell KP (1997) Direct binding of G-protein bg complex to voltage-dependent calcium channels. Nature 385: 446-450
8. European Malignant Hyperpyrexia Group (1984) A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. Br J Anaesth 56:1267-1269
9. Gillard EF, Otsu K, Fujii J, Khanna VK, DeLeon S, Derdemezi J, Britt BA, et al (1991) A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics 11:751-755
10. Grabner M, Friedrich K, Knaus HG, Striessnig J, Scheffauer F, Staudinger R, Koch WJ, et al (1991) Calcium channels from Cyprinus carpio skeletal muscle. Proc Natl Acad Sci USA 88:727-731
11. Gregg RG, Couch F, Hogan K, Powers PA (1993a) Assignment of the human gene for the α1-subunit of the skeletal muscle DHP-sensitive Ca2+ channel (CACNL1A3) to chromosome 1q31-q32. Genomics 15:107-112
12. Gregg R, Powers P, Hogan K (1993b) Assignment of the human gene for the β subunit of the voltage dependent calcium channel (CACNLB1) to chromosome 17 using somatic cell hybrids and linkage mapping. Genomics 15:186-187
13. Hogan K, Gregg RG, Powers PA (1996) The structure of the gene encoding the human skeletal muscle α1-subunit of the dihydropyridine-sensitive L-type calcium channel (CACNL1A3). Genomics 31:392-394
14. Hogan K, Powers PA, Gregg RC (1994) Cloning of the human muscle α1-subunit of the dihydropyridine-sensitive L-type calcium channel (CACNL1A3). Genomics 24:608-609
15. Iles DE, Lehmann-Horn F, Scherer SW, Tsui LC, Weghuis DO, Suijkerbuijk RF, Heytens L, et al (1994a) Localization of the gene encoding the α2/δ subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families. Hum Mol Genet 3:969-975
16. Iles DE, Segers B, Heytens L, Sengers RCA, Wieringa B (1992) High-resolution physical mapping of four microsatellite repeat markers near the RYRl locus on chromosome 19q13.1 and apparent exclusion of the MHS locus from this region in two malignant hyperthermia susceptible families. Genomics 14:749-754
17. Iles DE, Segers B, Olde Weghuis D, Suijkerbuijk R, Mikala G, Schwartz A, Wieringa B (1994b) Refined localization of the α1-subunit of the skeletal muscle L-type voltage dependent calcium channel (CACNL1A3) to human chromosome 1q32 by in situ hybridization. Genomics 19:561-563
18. Iles DE, Segers B, Sengers RCA, Monsieur K, Heytens L, Halsall PJ, Hopkins PM, et al (1993) Genetic mapping of the β1- and γ-subunits of the human skeletal muscle L-type voltage-dependent calcium channel on chromosome 17q and exclusion as candidate genes for malignant hyperthermia susceptibility. Hum Mol Genet 2:863-868
19. Jeanpierre M (1987) A rapid method for the purification of DNA from blood. Nucleic Acids Res 15:9611
20. Jurkat-Rott K, Lehmann-Horn F, Elbaz A, Heine R, Gregg RG, Hogan K, Powers PA, et al (1994) A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet 3:914-917
21. Kalasz H, Watanabe T, Yabana H, Itagaki K, Naito K, Nakayama H, Schwartz A, et al (1993) Identification of 1,4-dihydropyridine binding domains within the primary structure of the α1-subunit of the skeletal muscle L-type calcium channel. FEBS Lett 331:177-181
22. Kalow W (1987) Inheritance of malignant hyperthermia - a review of published data. In: Britt BA (ed) Malignant hyperthermia. Martinus-Nijhoff, Amsterdam and Boston, pp 155-180
23. Lambert C, Blanloeil Y, Krivosic-Horber R, Berard L, Reyford H, Pinaud M (1994) Malignant hyperthermia in a patient with hypokalemic periodic paralysis. Anesth Analg 79: 1012-1014
24. Larach M (1989) Standardization of the caffeine halothane muscle contracture test. Anesth Analg 69:511-515
25. Lathrop GM, Lalouel JM (1984) Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet 36:460-465
26. Lehmann-Horn F, Iaizzo PA (1990) Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia? Br J Anaesth 65:692-697
27. Levitt RC, Olckers A, Meyers S, Fletcher JE, Rosenberg H, Isaacs H, Meyers DA (1992) Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q. Genomics 14:562-566
28. MacLennan DH, Duff C, Zorzato F, Fujii J, Phillips M, Korneluk RG, Frodis W, et al (1990) Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature 343:559-561
29. MacLennan DH, Phillips M (1992) Malignant hyperthermia. Science 256:789-794
30. Malouf NN, McMahon DK, Hainsworth CN, Kay BK (1992) A two-motif isoform of the major calcium channel subunit in skeletal muscle. Neuron 8:899-906
31. Marty I, Robert M, Villaz M, DeJongh KS, Lai Y, Catteral WA, Ronjat M (1994) Biochemical evidence for a complex involving dihydropyridine receptor and ryanodine receptor in triad junctions of the skeletal muscle. Proc Natl Acad Sci USA 91:2270-2274
32. McCarthy TV, Healy JMS, Heffron JJA, Lehane M, Deufel T, Lehmann-Horn F, Farrall M, et al (1990) Localization of the malignant hyperthermia locus to human chromosome 19q12-13.2. Nature 343:562-564
33. McKusick VA (ed) (1990) Mendelian inheritance in man. Johns Hopkins University Press, Baltimore and London
34. Nakai J, Dirksen RT, Nguyen HT, Pessah IN, Beam KG, Allen PD (1996) Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor. Nature 380: 72-74
35. Olckers A, Meyers DA, Meyers S, Taylor EW, Fletcher JE, Rosenberg H, Isaacs H, et al (1992) Adult muscle sodium channel α-subunit is a candidate gene for malignant hyperthermia susceptibility. Genomics 14:829-831
36. 2+ channel (CACNLG), cDNA sequence, gene structure and chromosomal location. J Biol Chem 268:9275-9279
37. Powers P, Scherer SW, Tsui L, Gregg RG, Hogan K (1994) Localization of the gene encoding the α2/δ subunit (CACNL2) of the human skeletal muscle voltage dependent calcium channel to chromosome 7q21-22 by somatic cell hybrid analysis. Genomics 19:192-193
38. Pragnell M, de Waard M, Mori Y, Tanabe T, Snutch TP, Campbell KP (1994) Calcium channel β-subunit binds to a conserved motif in the I-II cytoplasmic linker of the α1-subunit. Nature 368:67-70
39. Ptacek LJ, Gouw L, Kwiecinski H, McManis PG, Mendell J, George AL, Barchi RL, et al (1993) Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis. Ann Neurol 33:300-307
40. Ptacek LJ, Tawil R, Griggs RC, Engel AG, Layzer RB, Kwiecinski H, McManis PG, et al (1994) Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77: 863-868
41. Quane KA, Healy JMS, Keating KE, Manning BM, Couch FJ, Palmucci LM, Doriguzzi C, et al (1993) Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat Genet 5:51-55
42. Quane KA, Keating KE, Healy JMS, Manning BM, Krivosic-Horber R, Krivosic I, Monnier N, et al (1994a) Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel tyr to ser mutation in a pedigree with associated central cores. Genomics 23:236-239
43. Quane KA, Keating KE, Manning BM, Healy JMS, Monsieurs K, Heffron JJA, Lehane M, et al (1994b) Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implication for diagnosis and heterogeneity studies. Hum Mol Genet 3:471-476
44. Sudbrak R, Golla A, Hogan K, Powers PA, Gregg RG, Du Chesne I, Lehmann-Horn, et al (1993) Exclusion of malignant hyperthermia susceptibility (MHS) from a putative MHS2 Locus on chromosome 17q and of the α1-, β1, and γ-subunits of the dihydropyridine receptor calcium channel as candidates for the molecular defect. Hum Mol Genet 2: 857-862
45. Sudbrak R, Procaccio V, Klausnitzer M, Curran JL, Monsieurs K, Van Broeckhoven C, Ellis R, et al (1995) Mapping of a further malignant hyperthermia susceptibility locus to chromosome 3q13.1. Am J Hum Genet 56:684-691
46. Sunada Y, Campbell K (1995) Dystrophin-glycoprotein complex: molecular organization and critical roles in skeletal muscle. Curr Opin Neurol 8:379-384
47. Takekura H, Bennett L, Tanabe T, Beam KG, Franzini-Armstrong C (1994) Restoration of junctional tetrads in dysgenic myotubes by dihydropyridine receptor DNA. Biophys J 67: 793-803
48. Tanabe T, Beam KG, Adams BA, Niidome T, Numa S (1990) Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling. Nature 346:567-569
49. Tanabe T, Takeshima H, Mikami A, Flockerzi V, Takahashi H, Kangawa K, Kojima M, et al (1987) Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature 328:313-318
50. Zamponi GW, Bourinet E, Nelson D, Nargeot J, Snutch TP (1997) Crosstalk between G proteins and protein kinase C mediated by the calcium channel α1-subunit. Nature 385: 442-446
51. Zhang Y, Chen HS, Khanna VK, De Leon S, Phillips M, Schappert K, Britt BA, et al (1993) A mutation in the human ryanodine receptor gene associated with central core disease. Nat Genet 5:46-51
52. Zheng W, Feng G, Ren D, Eberl DF, Hannan F, Dubald M, Hall LM (1995) Cloning and characterization of a calcium channel α1-subunit from Drosophila melanogaster with similarity to the rat brain type D isoform. J Neurosci 15: 1132-1143